Marte K. Viken's project group: HLA and Disease

Marte K. Viken
Marte K. Viken

Our group is primarily focused on studying immunological genes in complex diseases, with a particular focus on some of the most important immunological genes in the human genome, the human leukocyte antigen (HLA) genes. Key questions are how these immune genes are involved in disease development, disease progression and potential treatment. By doing genetic studies, we can uncover important clues relevant for both disease predisposition and disease progression. These genes can influence treatment; hence, understanding their role in disease is instrumental for future precision medicine. 

Research project overview

  • Immunogenetic studies of ME/CFS
  • Identifying pathogenic cell phenotypes in ME/CFS and Narcolepsy type 1 patients
  • Gene expression of HLA genes
  • Gene regulation of ERAP genes 

Contact information:

Project group leader Marte K. Viken, Oslo University hospital